Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Repaglinide Teva“
Suchtreffer
Begriffe & Kennungen
Clopidogrel Teva (hydrogen sulphate) · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenIrbesartan Teva · 4.5 · 5 Repaglinide Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbes
Eintrag öffnenIrbesartan/Hydrochlorothiazide Teva · 4.5 · Repaglinide Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesar
Eintrag öffnenRepaglinide Teva
Eintrag öffnenRepaglinide Teva · 4.1 Therapeutic indications · 1
Eintrag öffnenRepaglinide Teva · 4.3 Contraindications · 1
Eintrag öffnenRepaglinide Teva · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Diabetes melli
Eintrag öffnenRepaglinide Teva · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenRepaglinide Teva · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenRepaglinide Teva · 4.5 · 4 repaglinide metabolism with CYP3A4 playing a minor role, but the relative contribution of CYP3A4 can be incr
Eintrag öffnenRepaglinide Teva · 4.5 · 5 In a study conducted in healthy volunteers, the concomitant administration of repaglinide (a single dose of
Eintrag öffnenRepaglinide Teva · 4.5 · A number of medicinal products are known to influence repaglinide metabolism. Possible interactions should the
Eintrag öffnenRepaglinide Teva · 4.5 · Based on in vitro data, repaglinide appears to be a substrate for active hepatic uptake (organic anion transpo
Eintrag öffnenRepaglinide Teva · 4.5 · Co-administration of cimetidine, nifedipine, oestrogen, or simvastatin with repaglinide, all CYP3A4 substrates
Eintrag öffnenRepaglinide Teva · 4.5 · Co-administration of gemfibrozil (600 mg twice daily), an inhibitor of CYP2C8, and repaglinide (a single dose
Eintrag öffnenRepaglinide Teva · 4.5 · Co-administration of trimethoprim (160 mg twice daily), a moderate CYP2C8 inhibitor, and repaglinide (a single
Eintrag öffnenRepaglinide Teva · 4.5 · In an interaction study with healthy volunteers, co-administration of clopidogrel (300 mg loading dose), a CYP
Eintrag öffnenRepaglinide Teva · 4.5 · In an interaction study with healthy volunteers, co-administration of deferasirox (30 mg/kg/day, 4 days), a mo
Eintrag öffnenRepaglinide Teva · 4.5 · In vitro data indicate that repaglinide is metabolised predominantly by CYP2C8, but also by CYP3A4. Clinical d
Eintrag öffnenRepaglinide Teva · 4.5 · Paediatric population No interaction studies have been performed in children and adolescents.
Eintrag öffnen